BUZZ-Natera 推出新型罕见病基因检测后股价上涨

路透中文
Mar 12
BUZZ-Natera 推出新型罕见病基因检测后股价上涨

3月12日 - ** 基因检测公司NateraNTRA.O的股价盘前上涨1.4%至197.59美元

** 公司推出全基因组测序测试Zenith Genomics,旨在加快罕见病和超罕见病的诊断 - NTRA

** 该公司表示,罕见疾病影响着约3000万美国人,诊断可能需要数年时间

** 测试旨在发现难以检测的遗传疾病,并帮助指导治疗和长期护理

** Zenith Genomics与基因组分析公司MyOme合作开发,将利用Natera公司现有的网络在全美提供服务 - NTRA

** 该公司表示,基因检测的使用和保险覆盖面不断扩大,将支持基因检测的应用

** 2025 年股价上涨约 44%

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10